ECL

Ecolab
D

ECL

Arincen78/100B

Ecolab financials

Yes. Ecolab earned 2.08B USD of net income over the last twelve months, 12.0% of its revenue. It made a profit in 38 of its 40 fiscal years since 1986. Its last loss was in fiscal year 2020.

Revenue (TTM)
17.37B USD
Net income (TTM)
2.08B USD
Free cash flow (TTM)
1.80B USD
Cash and short-term investments
722.30M USD
Total debt
13.77B USD
Shareholders' equity
10.42B USD

Cash, debt and equity as of 30 Sept 2026.

Ecolab earnings

Next earnings · Q4 FY2026
EPS estimate
2.19 USD
Revenue estimate
4.75B USD
Last quarter · Q3 FY2026
EPS2.18Beat 0.0%Revenue4.69BMissed -0.1%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20272.56——+17.63%4.98B——+6.17%
Q2 FY20272.31——+10.56%4.86B——+10.15%
Q1 FY20271.89——+11.03%4.50B——+10.65%
Q4 FY20262.19——+5.29%4.75B——+13.34%
Q3 FY20262.182.180.00%+5.31%4.70B4.69B-0.11%+12.72%
Q2 FY20262.082.09+0.48%+10.58%4.38B4.42B+0.75%+9.69%
Q1 FY20261.701.700.00%+13.33%4.03B4.07B+0.99%+10.04%
Q4 FY20252.072.08+0.48%+14.92%4.19B4.19B+0.05%+4.67%
Q3 FY20252.072.070.00%+13.11%4.12B4.17B+1.07%+4.16%
Q2 FY20251.901.89-0.53%+12.50%4.02B4.03B+0.12%+0.99%

Ecolab growth and profitability

Full income statement
Revenue (TTM)
17.37B USD
Net income (TTM)
2.08B USD
Gross margin
43.94%
Operating margin
17.13%
Net margin
11.99%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY202516.08B+2.16%2.08B-1.74%44.51%18.11%12.91%3.46B-9.97%
FY202415.74B+2.75%2.11B+53.93%43.47%16.60%13.42%3.85B+26.74%
FY202315.32B+7.98%1.37B+25.70%40.32%14.10%8.96%3.03B+19.17%
FY202214.19B+11.42%1.09B-3.38%38.20%11.34%7.69%2.55B+2.92%
FY202112.73B+8.00%1.13B—41.01%13.23%8.87%2.47B+11.41%

How Ecolab makes its money

Global Water7.98B 49.6%
Global Institutional and Specialty6.10B 38.0%
Global Pest Elimination1.25B 7.8%
Global Life Sciences747.90M 4.7%
Revenue16.08B 100.0%
Cost of revenue8.92B 55.5%
Gross profit7.16B 44.5%
Selling and administration4.26B 26.5%
Operating income2.91B 18.1%
Tax454.60M 2.8%
Other expense382.40M 2.4%
Net income2.08B 12.9%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

Ecolab revenue breakdown

By product

FY2025
Global Water: 49.6%Global Institutional and Specialty: 38.0%Global Pest Elimination: 7.8%Global Life Sciences: 4.7%49.6%Global Water38.0%Global Institutional and Specialty7.8%Global Pest Elimination4.7%Global Life Sciences
SegmentRevenueShare of revenueChange on the year
Global Water7.98B49.6%—
Global Institutional and Specialty6.10B38.0%+12.8%
Global Pest Elimination1.25B7.8%+6.7%
Global Life Sciences747.90M4.7%—

By region

FY2025
United States: 52.7%Europe: 20.4%Asia Pacific: 8.5%Latin America: 6.8%C [N]: 4.5%Middle East And Africa: 4.0%Canada: 3.1%52.7%United States20.4%Europe8.5%Asia Pacific6.8%Latin America4.5%C [N]4.0%Middle East And Africa3.1%Canada
RegionRevenueShare of revenueChange on the year
United States8.48B52.7%+2.1%
Europe3.28B20.4%+2.6%
Asia Pacific1.36B8.5%+1.7%
Latin America1.10B6.8%+0.1%
C [N]722.40M4.5%+3.7%
Middle East And Africa638.20M4.0%+2.1%
Canada499.40M3.1%+4.3%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY20252.95B1.90B
FY20242.81B1.82B
FY20232.41B1.64B
FY20221.79B1.08B
FY20212.06B1.42B
FY20201.86B1.37B
FY20192.42B1.69B
FY20182.28B1.43B
FY20172.09B1.22B
FY20161.94B1.18B

Ecolab financial health

Full balance sheet
Cash and short-term investments
722.30M USD
Total debt
13.77B USD
Net cash
-13.05B USD
Free cash flow (TTM)
1.80B USD
Current ratio
1.11
Debt to equity
1.32
Piotroski score
5 / 9
Altman Z-score
4.01

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY2025646.20M9.43B1.90B
FY20241.26B8.28B1.82B
FY2023919.50M8.73B1.64B
FY2022598.60M9.03B1.08B
FY2021359.90M9.16B1.42B

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY202524.70B14.89B9.77B
FY202422.39B13.60B8.76B
FY202321.85B13.77B8.04B
FY202221.46B14.21B7.24B
FY202121.21B13.95B7.22B
FY202018.13B11.92B6.17B
FY201920.87B12.14B8.69B
FY201820.07B12.02B8.00B
FY201719.96B12.27B7.62B
FY201618.33B11.36B6.90B

Ecolab valuation

Price to earnings ratio (TTM)
41.69
Forward P/E (FY2026)
37.86
Price to sales (TTM)
4.99
Price to book
8.31
EV / EBITDA (TTM)
27.43

Capital structure

Market capitalization
86.63B USD
+
Total debt
13.77B USD
−
Cash and short-term investments
722.30M USD
=
Enterprise value
99.68B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)28.75————
FY2027 (est.)32.8528.75———
FY2026 (est.)37.8632.85———
Now (TTM)41.6933.434.998.3127.43
FY202535.8132.194.627.6124.02
FY202431.5431.114.237.6119.15
FY202341.1529.893.697.0321.21
FY202238.0128.082.935.7419.62
FY202159.3952.485.279.3030.71

Ecolab against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: The Sherwin-Williams, Air Products and Chemicals, PPG Industries, International Flavors & Fragrances, RPM International, and Albemarle, the US Chemicals - Specialty companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Above its median41.7
    30.459.7
  • Gross marginHighest in 5 years44.5%
    38.2%44.5%
    Against its peers: 2 of 7Peers' median 37.1%
  • Operating marginHighest in 5 years18.1%
    11.3%18.1%
    Against its peers: 1 of 7Peers' median 9.7%
  • Net marginAbove its median12.9%
    7.7%13.4%
    Against its peers: 1 of 7Peers' median 6.3%
  • Return on equityAbove its median21.2%
    15.1%24.1%
    Against its peers: 2 of 6Peers' median 19.8%
  • Free cash flow marginHighest in 5 years11.8%
    7.6%11.8%
    Against its peers: 2 of 7Peers' median 8.0%
  • Revenue growthLowest in 5 years2.2%
    2.2%11.4%
    Against its peers: 3 of 7Peers' median 1.1%
  • EPS growthBelow its median-1.2%
    -2.6%53.9%
    Against its peers: 2 of 5Peers' median -3.0%
  • Debt to EBITDABelow its median2.72×
    2.15×3.70×
    Against its peers: 2 of 6Peers' median 2.89×
  • Current ratioLowest in 5 years1.08
    1.081.32
    Against its peers: 5 of 6Peers' median 1.62

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Ecolab dividends

Annual dividend
2.92 USD
Dividend yield (indicated)
0.95%
Payout ratio
39.41%
Years of dividend growth
39
Frequency
Quarterly
Last payment
0.73 USD
Last ex-dividend date
15 Sept 2026
Last payment date
15 Oct 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share2.602.282.122.041.921.881.841.641.481.40

Ecolab ownership

Institutions
80.84%
Institutional holders
1,756 (+10)
Free float
89.45%

Who owns the shares

Institutions 80.8% Others 19.2%
As of 30 Jun 2026

Shares free to trade

Free float 250.88M shares ·89.5% Closely held 29.59M shares ·10.5%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 20260018.98K19.27K
Q3 20262316.02K39.16K
Q2 20264242.15K36.22K
Q1 202607104.40K107.85K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025283.30M285.20M-0.49%
FY2024284.30M286.60M+0.03%
FY2023285.00M286.50M-0.03%
FY2022285.20M286.60M-0.86%
FY2021286.30M289.10M+0.73%

Common questions about Ecolab's financials

Source: Financial Modeling Prep